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Abstract
Objective: Single nucleotide polymorphisms (SNPs) in genes involved in fatty acid metabolism (FADS1 FADS2 gene cluster)
are associated with plasma lipid levels. We aimed to investigate whether these associations are already present early in life
and compare the relative contribution of FADS SNPs vs traditional (non-genetic) factors as determinants of plasma lipid
levels.
Methods: Information on infants’ plasma total cholesterol levels, genotypes of five FADS SNPs (rs174545, rs174546,
rs174556, rs174561, and rs3834458), anthropometric data, maternal characteristics, and breastfeeding history was available
for 521 2-year-old children from the KOALA Birth Cohort Study. For 295 of these 521 children, plasma HDLc and non-HDLc
levels were also known. Multivariable linear regression analysis was used to study the associations of genetic and non-
genetic determinants with cholesterol levels.
Results: All FADS SNPs were significantly associated with total cholesterol levels. Heterozygous and homozygous for the
minor allele children had about 4% and 8% lower total cholesterol levels than major allele homozygotes. In addition,
homozygous for the minor allele children had about 7% lower HDLc levels. This difference reached significance for the SNPs
rs174546 and rs3834458. The associations went in the same direction for non-HDLc, but statistical significance was not
reached. The percentage of total variance of total cholesterol levels explained by FADS SNPs was relatively low (lower than
3%) but of the same order as that explained by gender and the non-genetic determinants together.
Conclusions: FADS SNPs are associated with plasma total cholesterol and HDLc levels in preschool children. This brings a
new piece of evidence to explain how blood lipid levels may track from childhood to adulthood. Moreover, the finding that
these SNPs explain a similar amount of variance in total cholesterol levels as the non-genetic determinants studied reveals
the potential importance of investigating the effects of genetic variations in early life.
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Introduction
Elevated total cholesterol (TC), low-density lipoprotein choles-
terol (LDLc), and very-low-density lipoprotein cholesterol levels,
and low levels of high-density lipoprotein cholesterol (HDLc) levels
early in life play a role in the development of adult atherosclerosis,
one of the major risk factors of coronary artery disease [1]. This
may be partly explained by the fact that plasma lipid levels track
from childhood into adulthood [2–4], and correlate with the
extent of fatty streaks in early life (early atherosclerotic lesions
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which may progress to advanced atherosclerotic lesions and
coronary artery disease) [1,5]. Therefore, the understanding and
control of determinants of plasma lipid levels in childhood is of
utmost importance. With such aim in mind, several studies have
identified significant associations between maternal anthropomet-
ric characteristics and lifestyle [6], and children’s characteristics
such as gender [7–9], anthropometric characteristic [7,9], early
diet [8,10,11], and breastfeeding [12], with children’s plasma lipid
levels. Genetic determinants appear to be relevant as well. At least
in adults, many single nucleotide polymorphisms (SNPs), each with
modest effects, have been found to explain part of the inter-
individual variability in plasma lipid levels [13–16].
We and others demonstrated that SNPs in the genes coding for
the fatty acid desaturases 5 and 6 (FADS1 FADS2 gene cluster) are
associated with the proportions of the various polyunsaturated
fatty acids (PUFAs) in adults’ blood and tissues [17,18] and in
plasma phospholipids of 2-year-old infants [19]. As expected,
FADS SNPs also showed associations with cardiovascular-related
outcomes influenced by PUFAs such as the risk of type 2 diabetes
[20,21], coronary artery disease [22], myocardial infarction [23],
and metabolic syndrome [24]. In addition, FADS SNPs were found
to be associated with intermediate phenotypes such as serum or
plasma lipid levels in adults and adolescents [13–16,22,23,25–34].
Recently, Standl et al. showed that the associations between FADS
SNPs and blood lipid levels are already present in 10-year-old
children [35], which raises the question as to whether such
associations can be detected even earlier in life.
In the present study we investigated: 1) whether FADS SNPs
were associated with TC, HDLc, and non-high-density lipoprotein
cholesterol (nHDLc) levels in 2-year old infants, and 2) the
contribution of FADS SNPs in determining plasma lipid levels
compared to traditional (non-genetic) determinants.
Methods
Ethics Statement
This study was approved by the Ethics Committee of the
Maastricht University/University Hospital Maastricht. All parents
gave written informed consent.
CohortThe details of the cohort have been described elsewhere
[36]. In summary, the KOALA Birth Cohort Study is a
prospective birth cohort in the center and South of the Nether-
lands. The recruitment of pregnant women started in 2000.
Between 2000 and 2002, healthy pregnant women participating in
the Pregnancy related Pelvic Girdle Pain Study (PPBS, n = 7526)
[37] were invited to participate with their child in the KOALA
study. Most women recruited by this means had a conventional
lifestyle in terms of diet and child rearing practices. Additional
pregnant women with alternative lifestyles were recruited from
2001 to 2002 through organic food shops, anthroposophic doctors
and midwives, and Steiner schools. In total, 2834 women were
recruited (n = 2343 conventional recruitment group; n = 491
alternative recruitment group) (figure 1). Women recruited from
2001 onwards were asked to consent to blood sampling in
pregnancy. When children were 2 years of age, parents were asked
to consent to children’s collection of buccal swabs and, if maternal
consent for blood collection in pregnancy was available, also to
children’s blood sampling (eligible children after exclusions,
n = 1337). Buccal swabs and blood were successfully collected in
1566 and 812 children, respectively. Due to limited volume of
plasma available, TC and HDLc levels were determined in 611
and 342 children, respectively, out of the 812 with blood sampled.
Exclusion criteria were: withdrawal from the study before
child’s birth, perinatal death, severe congenital diseases, metabolic
disorders, severe intellectual disabilities, cancer, and twins. For this
study, children of non-European ancestry were also excluded, as
blood lipid metabolism may be affected by ethnicity [38] and the
minor allele frequency of FADS SNPs differs between ethnic
groups [39]. Children’s ancestry was assessed by using information
about the country of birth of grandparents, collected through
questionnaires filled out by both parents. Children were consid-
ered to be of European descent when at least three of their
grandparents were born in countries of predominant European
ancestry.
The final study population consisted of 521 children with TC
analyzed and buccal swabs available, from which 295 children also
had HDLc analyzed.
Plasma Lipids
Non-fasting blood samples were collected in EDTA-tubes by
trained nurses, according to a standardized protocol, during a
home visit to the child around age 2 years. After centrifugation,
the EDTA-plasma was stored in cryovials at 280uC. TC and
HDLc were analyzed on an autoanalyser (LX20 Pro, Beckman
Coulter, Mijdrecht, The Netherlands) with two kits from Beckman
Coulter: Enzymatic method, nr. CHOL 467825 for TC and HDLD kit,
nr 650207 for HDLc. nHDLc was calculated as the difference
between TC and HDLc.
DNA Isolation and SNP Genotyping
The DNA isolation and SNP selection and genotyping have
been described in detail elsewhere [19]. In short, genomic DNA
was extracted from buccal swabs using standard methods [40], and
afterwards amplified by using REPLI-g UltraFast technology
(QiagenTM) as reported before [41]. Five variants of the FADS1
FADS2 gene cluster (rs174545, rs174546, rs174556, rs174561, and
rs3834458) were typed. These variants are associated with the
proportions of PUFAs in serum and plasma phospholipids and
erythrocytes’ membranes from adults [42–44] and children [19].
Additionally, the SNPs rs174545, rs174546, and rs174556 were
estimated to tag up to 21 SNPs between basepair positions
61300075 and 61379716 of FADS1 FADS2, by using the Tagger
tool (http://www.broad.mit.edu/mpg/tagger [45]) with HapMap
release 21 data. Genotyping was performed with the iPLEX
method (Sequenom, San Diego, CA, USA) by Matrix Assisted
Laser Desorption/Ionization Time Of Flight Mass Spectrometry
(MALDI-TOF MS, Mass Array; Sequenom).
Maternal and Children’s Information
Information on potential non-genetic determinants of children’s
plasma lipids and possible confounders was retrieved from
obstetric reports and questionnaires filled out at different time
points during pregnancy and the first two years of children’s life
(table 1). Maternal and children’s BMIs were calculated as kg/
m2. In order to standardize children’s BMI for gender and actual
age of measurement (which could slightly differ among children),
measurements were converted to standard deviation scores (z-
scores) using data from the Dutch reference population as the
standard [46].
Statistical Analyses
All analyses were performed with PASW Statistics 18.
Agreement of the genotype frequencies with Hardy-Weinberg
Equilibrium expectations was tested by chi-square test. Normality
of blood lipids was checked by means of histograms and Q-Q-
plots.
FADS Genes and Plasma Cholesterol at Age 2 Years
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Associations of genetic and non-genetic determinants with
plasma lipid levels were examined in multivariable linear
regression models (table 2). The associations between FADS
genotypes and plasma lipids were tested in model 1 assuming a co-
dominant genetic model. Statistical significance was defined by a
two-sided alpha level of 5%. Correction for multiple testing was
performed by the method proposed by Nyholt [47]. In brief, this
method takes into account the correlation pattern between the
SNPs and reduces the number of variables in a set to the effective
number of variables, which is an estimate of the number of
independent tests. We divided the alpha level of 5% by the
effective number of independent SNPs (1.26 in our case), yielding
a significance threshold of 0.040 required to keep Type I error rate
at 5%.
To test the associations of non-genetic determinants and gender
with plasma lipid levels, we started with model 2 (table 2) which
included gender, maternal smoking and alcohol intake during
pregnancy, maternal age at delivery, prepregnancy BMI, and
parity. Subsequently, we built models 3, 4, 5, and 6 by successively
adding the determinants pregnancy weight gain, gestational age at
delivery, breastfeeding duration, and birth weight. This allowed us
to check the absence of overadjustment bias in the final model 6.
Such bias could exist when including in a model intermediate
variables on a causal pathway from exposure to outcome [48] (e.g.
if birth weight would mediate the association between maternal
smoking during pregnancy and children’s plasma lipid levels, the
inclusion of the former in a model already including maternal
smoking could bias the results). Finally, we built model 7, including
both genetic and non-genetic determinants. As plasma lipid levels
Figure 1. Flow diagram of the study design and participant selection.
doi:10.1371/journal.pone.0061671.g001
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may be differently modulated in boys and girls, and some SNPs
have been found to exert different effects according to gender [49],
the genotype-gender interaction was also tested in this model.
For handling missing data in continuous determinants (table 3),
we first performed the Little’s Missing Completely at Random test
[50], which showed that missing data did not deviate from the
‘‘missing completely at random’’ assumption. Secondly, we
imputed missing values through the expectation maximization
algorithm using information on maternal age, education, smoking
during pregnancy, alcohol intake during pregnancy, gestational
age, pre-pregnancy BMI, pregnancy weight gain, birth weight,
and child’s gender. Missing values in categorical variables (table 4)
were coded as a new category. Cases with missing data for SNPs
were excluded from the analyses involving that particular SNP.
Results
Children’s mean age at blood collection was 25.3 months
(range = 22.6–30.6) and did not differ between boys and girls. As
shown in tables 3 and 4, the group with both TC and HDLc
analyzed (group 4) virtually did not differ from that with only TC
(group 3) with regard to any of the variables relevant for this study.
The same was true when comparing group 3 and 4 with group 1
(candidates for blood collection) and 2 (children with successful
blood sampling). Plasma lipid levels were normally distributed.
Mean values (6SD) for TC, HDLc, and nHDLc of children at 2
years were 3.80 (60.62), 1.01 (60.22), and 2.84 (60.63) mmol/L,
respectively.
Table 1. Maternal and children’s non-genetic potential determinants of blood lipids, possible confounders, and data source.
Maternal information Source
Determinants Maternal age at delivery Q*+obstetric report
Smoking habits during pregnancy Q at 14 and 30 wk pregnancy
Alcohol intake during pregnancy Q at 14 and 30 wk pregnancy
Weight and height before pregnancy Q at 14 and 30 wk pregnancy
Pregnancy weight gain Q at 2 wk post-partum
Parity before index pregnancy Q at 30 wk pregnancy
Confounders Maternal education Q at 14 wk pregnancy
Recruitment group Recorded at the time of recruitment
Children’s information Source
Determinants Gender Q+obstetric report
Gestational age at delivery Q at 2 wk post-partum
Birth weight Obstetric report
Weight and height at 2 years Q at 2 years post-partum
Breastfeeding duration Q at 2 wk, 3, 6, 7, 12, and 22 mo post-partum
Confounders Age at blood collection Recorded at the time of blood collection
*Q stands for ‘‘questionnaire’’.
doi:10.1371/journal.pone.0061671.t001
Table 2. Variables included in each of the seven examined linear regression models.
Potential determinants of blood lipids included in the models Regression models nr.*
1 2 3 4 5 6 7
FADS SNPs x x
Gender x x x x x x
Maternal smoking during pregnancy x x x x x x
Maternal alcohol intake during pregnancy x x x x x x
Maternal age at delivery x x x x x x
Pre-pregnancy BMI x x x x x x
Parity before the index pregnancy x x x x x x
Pregnancy weight gain x x x x x
Gestational age at delivery x x x x
Breastfeeding duration x x x
Birth weight x x
*Recruitment group and age of blood collection were adjusted for in all models, and maternal education was adjusted for in models 2 to 7.
doi:10.1371/journal.pone.0061671.t002
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Associations between SNPs and Plasma Lipid Levels
SNPs characteristics and genotype and minor allele frequencies
are shown in table 5. All SNPs were in Hardy Weinberg
equilibrium. According to the regression coefficients obtained in
model 1 (table 6), heterozygous children (Mm) for the SNP
rs174545 had about 0.15 mmol/L lower TC than children
Table 3. Representativeness of the study participants regarding continuous variables.
Group 1 (n = 1337)* Group 2 (n = 812)* Group 3 (n = 521)* Group 4 (n = 295)*
n# Mean SD n# Mean SD n# Mean SD n# Mean SD
Maternal age at delivery (years) 1320 32,54 3,80 807 32,80 3,82 516 32,90 3,81 292 32,82 3,62
Gestational age (weeks) 1316 39,7 1,2 805 39,6 1,2 516 39,7 1,2 292 39,7 1,1
Maternal pre-pregnancy height (cm) 1336 170,01 6,37 812 170,01 6,40 521 170,15 6,36 295 170,08 6,02
Maternal pre-pregnancy weight (kg) 1332 67,68 11,65 809 67,95 11,53 519 68,32 11,26 293 68,09 10,59
Maternal weight gain pregnancy (kg) 1241 14,32 5,01 761 14,08 4,79 490 14,10 4,78 281 14,39 4,69
Breastfeeding duration (months) 1327 5,7 4,4 812 5,7 4,4 521 5,9 4,4 295 5,8 4,5
Total cholesterol child (mmol/L) NA NA NA 611 3,80 0,63 521 3,80 0,62 295 3,85 0,62
HDL cholesterol child (mmol/L) NA NA NA 342 1,01 0,22 295 1,01 0,22 295 1,01 0,22
Non-HDL cholesterol child (mmol/L) NA NA NA 342 2,84 0,63 295 2,84 0,63 295 2,84 0,63
Birth weight (g) 1330 3556 476 812 3562 482 521 3579 456 295 3593 469
Weight at 2 years (z-score) 1169 20,13 0,96 765 20,16 0,95 497 20,14 0,94 276 20,05 0,93
Length at 2 years (z-score) 1161 20,12 1,07 758 20,14 1,06 494 20,08 1,05 277 20,01 1,02
BMI at 2 years (z-score) 1150 20,01 1,02 754 20,04 1,00 491 20,07 1,02 275 20,02 0,98
*Groups agree with those defined in Figure 1: group 1 = children candidate for blood collection; group 2 = children with blood sampling successful; group 3 = children
with total cholesterol analyzed and genotypes available; group 4 = children with total cholesterol and HDLc analyzed and genotypes available.
#May differ from the total due to missing values.
doi:10.1371/journal.pone.0061671.t003
Table 4. Representativeness of the study participants regarding categorical variables.
Variable Categories Group 1 (n = 1337)* Group 2 (n = 812)* Group 3 (n = 521)* Group 4 (n = 295)*
Frequency % Frequency % Frequency % Frequency %
Sex Boys 679 50,8 424 52,2 261 50,1 147 49,8
Girls 658 49,2 388 47,8 260 49,9 148 50,2
Maternal
education
Primary school or lower vocational 41 3,1 27 3,4 19 3,7 8 2,7
Secondary school or middle vocational 561 42,9 337 42,1 208 40,5 132 45,4
Higher vocational, or university degree
or higher
707 54,0 437 54,6 287 55,8 151 51,9
Missings 28 – 11 – 7 – 4 –
Maternal
smoking at any
No 1244 94,4 764 94,9 497 96,7 280 96,6
time during
pregnancy
Yes 74 5,6 41 5,1 17 3,3 10 3,4
Missings 19 – 7 – 7 – 5 –
Alcohol intake
during
No 1072 81,2 654 81,0 431 83,5 238 81,5
pregnancy Yes 248 18,8 153 19,0 85 16,5 54 18,5
Missings 17 – 5 – 5 – 3 –
Parity before
index
0 545 41,3 311 38,5 199 38,6 109 37,3
Pregnancy 1 562 42,6 366 45,4 232 45,0 133 45,5
$2 213 16,1 130 16,1 85 16,5 50 17,1
Missings 17 – 5 – 5 – 3 –
*Groups agree with those defined in Figure 1: group 1 = children candidate for blood collection; group 2 = children with blood sampling successful; group 3 = children
with total cholesterol analyzed and genotypes available; group 4 = children with total cholesterol and HDLc analyzed and genotypes available.
doi:10.1371/journal.pone.0061671.t004
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homozygous for the major allele (MM), and homozygous for the
minor allele children (mm) had 0.30 mmol/L lower TC than MM
children. These differences were significant even after correction
for multiple testing. The results for the other SNPs were highly
consistent with those for rs174545, both in terms of magnitude and
direction of the association. HDLc was lower in mm than in MM
children (with a difference of about 0.09 mmol/L that reached
significance for the SNPs rs174546 and rs3834458). Instead,
HDLc levels of Mm children did not differ much from those of
MM children. The possibility that the association between FADS
SNPs and HDLc levels was better explained by a recessive
compared to an additive genetic model was tested and confirmed
post-hoc by a partial F-test (at a level = 0.05). nHDLc levels were
also lower in carriers of the minor allele compared to MM
children, but the differences did not reach statistical significance.
Contribution of Genetic and Non-genetic Determinants
FADS genotypes explained 2.4–2.9% of the variance in TC
levels, 1.1–1.9% of the variance in HDLc levels, and 1.6–2.0% of
the variance in nHDLc (Table 6, model 1). Non-genetic
determinants explained 3.5, 4.1, and 10.4% of the variance in
TC, HDLc, and nHDLc levels, respectively (Table 7, model 6).
Compared with boys, girls had 0.17 and 0.20 mmol/L higher TC
and nHDLc, respectively. Parity was negatively associated with
nHDLc, so that children from women with 2 or more children
before the index pregnancy had 0.26 mmol/L lower nHDLc than
children from primipara women. This association was indepen-
dent from maternal age. Children in the highest quintile of
breastfeeding duration (breastfed for .11 months) had lower
nHDLc than those in the lowest quintile (breastfed for #1 month).
Lastly, birth weight showed a positive association with nHDLc
levels. The other determinants tested were not significantly
associated with blood lipid levels. The inclusion of BMI z-scores
at 2 years instead of birth weight in model 6 resulted in a positive
association between BMI z-score and nHDLc (b= 0.081, 95%
CI = 0.003, 0.158), as occurred with birth weight, and in a
negative association with HDLc (b=20.029, 95% CI =20.057,
0.000).
Results from model 7 (not shown) demonstrated that the
regression coefficients for the genetic and non-genetic determi-
nants were virtually the same as when the genetic and non-genetic
determinants were tested in two separate models (i.e. models 1 and
6, respectively), suggesting that each set of determinants were
independent from each other (i.e. no confounding). Moreover, the
percentages of variances explained by model 7 were close to the
sum of variances explained by genetic and non-genetic determi-
nants separately (Table S1). No significant interaction between
genotypes and gender was found.
Discussion
In the study presented here we show that the associations
between FADS SNPs genotypes and TC and HDLc levels are
already present in 2-year-old preschool children. In addition, we
report that FADS SNPs and non-genetic factors determine
cholesterol levels independently from each other and explain a
similar amount of variance in TC levels.
Plasma lipid levels were of the same order as seen in other
studies in 2–3 year-old infants, when all expressed in mmol/L
[2,7,11,38]. mm children had lower TC levels than children
homozygous for the major allele (MM) (table 6). HDLc and
nHDLc concentrations were also lower in minor allele carriers
than in MM children, but statistical significance was not reached in
all cases. The fact that the results for all SNPs were very consistent
regarding the direction and strength of the associations was
expected, based on the relatively high linkage disequilibrium (LD)
between the studied SNPs (r2$0.85, D9$0.99) [19]. The lack of
significance for nHDLc could be due to the smaller sample size
compared to TC, smaller effect sizes, or higher measurement error
(as nHDLc values derive from those of TC and HDLc).
Alternatively, it could be that an association with nHDLc is found
only when taking diet into account. In this line, Lu et al. and
Dumont et al. found that the association between carrying one or
two minor alleles of the FADS SNP rs174546 and having lower
nHDLc levels became significant only in subjects with high intake
of n-3 PUFAs or alpha-linolenic acid, respectively [25,34].
Unfortunately, we lacked information on infant’s diet and hence
could not investigate this possibility.
Expressing the absolute differences in cholesterol levels among
genotypes as percentages, heterozygous children (Mm) had about
4, 0.5, and 2.5% lower TC, HDLc, and nHDLc levels,
respectively, than MM children. Differences between mm and
MM children were about 8, 7, and 7% for TC, HDLc, and
nHDLc, respectively. This information reveals two interesting
points. First, the relative differences between genotype groups
seem to be larger in our population of preschool children than in
adults or adolescents. Three previous studies presented their data
in a way that allowed us to calculate the differences between
genotypes as percentage [25,29,34]; from these studies, differences
between MM and mm subjects appear to be lower than 4% for
either TC, HDLc, and nHDLc. The second observation is that,
while the association between FADS SNPs and TC seems to agree
with an additive genetic model (so that each copy of the minor
allele results in an additive decrease in TC, from 4% in Mm to 8%
in mm), the association with HDLc agrees better with a recessive
model. In this case, MM and Mm children have similar levels of
HDLc, and levels are lower only in the mm group. The hypothesis
Table 5. Genotype frequencies, minor allele frequencies (MAF), and location of the studied single nucleotide polymorphisms
(SNPs).
SNP (major/minor allele) MM Mm mm MAF (%) Location
rs174545 (C/G) 233 224 58 33 39 UTR FADS1
rs174546 (C/T) 234 223 59 33 39 UTR FADS1
rs174556 (C/T) 248 220 50 31 Intron FADS1
rs174561 (T/C) 251 218 51 31 Intron FADS1
rs3834458 (T/del) 233 227 59 33 Intergenic region FADS1-FADS2
‘‘MM’’, ‘‘Mm’’, and ‘‘mm’’ stand for homozygous for the major allele, heterozygous, and homozygous for the minor allele children, respectively.
Children with missing data on a specific genotype were excluded from the analyses involving such genotype.
doi:10.1371/journal.pone.0061671.t005
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that may follow this observation and that warrants further research
is that, from the three genotype groups, Mm subjects may have the
lowest TC/HDLc ratio and therefore potentially lower cardiovas-
cular risk.
The biological mechanisms explaining the associations between
FADS SNPs and cholesterol levels are unknown so far. They are
most probably related to the differences in fatty acids proportions
in blood and tissues among genotypes. It has been hypothesized
that lower percentages of long-chain PUFAs in subjects with the
Table 6. Associations between FADS gene variants and total cholesterol, HDLc, and nHDLc (model 1 according to Table 2).
Total cholesterol HDLc nHDLc
n R2 (%) b 95% CI p n R2 (%) b 95% CI p n R2 (%) b 95% CI p
rs174545 515 2.9 291 1.9 291 1.8
Mm vs MM –.154 –.267 –.041 .008 –.004 –.057 .050 .893 –.089 –.241 .062 .247
mm vs MM –.303 –.480 –.126 .001 –.092 –.180 –.003 .042 –.198 –.449 .053 .122
rs174546 516 2.7 293 1.9 293 1.8
Mm vs MM –.156 –.269 –.042 .007 –.008 –.062 .045 .760 –.099 –.252 .053 .201
mm vs MM –.286 –.463 –.110 .002 –.095 –.183 –.006 .037 –.197 –.450 .056 .127
rs174556 518 2.5 294 1.1 294 1.6
Mm vs MM –.142 –.255 –.029 .014 –.007 –.061 .047 .804 –.068 –.220 .084 .379
mm vs MM –.297 –.486 –.109 .002 –.072 –.167 .023 .136 –.247 –.514 .021 .070
rs174561 520 2.4 295 1.1 295 2.0
Mm vs MM –.147 –.259 –.034 .011 –.011 –.065 .042 .681 –.076 –.228 .076 .326
mm vs MM –.279 –.466 –.093 .003 –.074 –.168 .020 .124 –.251 –.518 .015 .065
rs3834458 519 2.6 295 1.8 295 1.7
Mm vs MM –.151 –.264 –.038 .009 –.006 –.060 .047 .818 –.093 –.244 .059 .231
mm vs MM –.289 –.466 –.112 .001 –.094 –.183 .005 .038 –.195 –.448 .057 .129
n: number of children included in the analysis; R2: percentage of variance explained (unadjusted R2); b: regression coefficient from linear regression analysis indicating
the difference in mmol/L between Mm and mm compared to MM (reference category), where MM, Mm, and mm stand for homozygous for the major allele,
heterozygous, and homozygous for the minor allele children, respectively; 95% CI: 95% confidence interval; p: p-value. Values in bold are statistically significant after
correction for multiple testing (p-value,0.040). Analyses were adjusted for recruitment group and age of children’s blood collection.
doi:10.1371/journal.pone.0061671.t006
Table 7. Associations between non-genetic maternal and infant’s characteristics and breastfeeding with total cholesterol, HDLc,
and nHDLc (model 6 according to Table 2).
Total cholesterol (n = 521) HDLc (n = 295) nHDLc (n = 295)
R2 (%) b 95% CI p R2 (%) b 95% CI p R2 (%) b 95% CI p
Gender (girl vs boy) 3.5 .166 .055 .278 .003 4.1 .008 –.047 .062 .785 10.4 .204 .055 .354 .008
Maternal smoking (Y vs N) .171 –.142 .483 .283 .042 –.105 .189 .576 .244 –.160 .648 .235
Maternal alcohol intake (Y vs N) –.122 –.276 .033 .123 –.007 –.077 .063 .851 –.002 –.194 .190 .982
Maternal age (years) .006 –.010 .022 .449 .002 –.005 .010 .537 .021 –.001 .042 .061
Pre-pregnancy BMI (kg/m2) –.002 –.018 .014 .791 .001 –.008 .009 .861 –.004 –.028 .020 .731
Parity before index pregnancy (1 vs 0) –.092 –.221 .037 .160 –.008 –.069 .053 .798 –.143 –.311 .025 .095
Parity before index pregnancy ($2 vs 0) –.060 –.237 .116 .503 –.018 –.102 .066 .674 –.256 –.486 –.026 .029
Pregnancy weight gain (kg) .004 –.009 .016 .541 .002 –.004 .008 .524 –.006 –.023 .010 .441
Gestational age (weeks) .018 –.035 .071 .496 –.007 –.033 .019 .613 .000 –.071 .071 .999
Breastfeeding duration* (quintile 2 vs1) –.066 –.244 .112 .467 –.020 –.105 .065 .645 –.212 –.445 .020 .074
Breastfeeding duration (quintile 3 vs1) –.022 –.192 .148 .799 –.010 –.093 .073 .817 –.202 –.429 .025 .081
Breastfeeding duration (quintile 4 vs1) –.068 –.248 .113 .463 –.002 –.091 .086 .956 –.052 –.294 .190 .675
Breastfeeding duration (quintile 5 vs1) –.127 –.322 .068 .202 .047 –.047 .141 .331 –.362 –.619 –.104 .006
Birth weight (kg) .022 –.114 .159 .749 .016 –.049 .081 .627 .210 .032 .388 .021
R2: percentage of variance explained (unadjusted R2); b: regression coefficient from linear regression analysis adjusting for recruitment group, age of children’s blood
collection, and maternal education; 95% CI: 95% confidence interval; p: p-value. Values in bold are statistically significant (p-value,0.05).
*Breastfeeding duration was divided into quintiles to correct for its skewed distribution and investigate the presence of dose-effects.
doi:10.1371/journal.pone.0061671.t007
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mm genotype may explain the lower HDLc levels as a result of
lower activation of the peroxisome proliferator activator receptor
alpha (which regulates the expression of genes directly involved in
HDL production). The lower LDLc observed in other studies, in
turn, could be explained by the higher percentages of linoleic acid
in mm subjects, which could increase membrane fluidity, enhance
LDL-receptor recycling, and ultimately lower LDLc levels [29].
Among the non-genetic determinants studied, gender, parity,
breastfeeding, and birth weight showed significant associations
with plasma cholesterol levels (table 7). Girls had higher TC and
nHDLc than boys, and children with higher birth weight had
higher nHDLc. These results are in line with those reported for
preschool children from the ALSPAC Study [7], where girls had
higher TC/HDLc ratio than boys, and boys with higher birth
weight had higher TC/HDLc ratio at 43 months of age. Although
TC/HDLc ratio and nHDLc levels cannot be directly compared,
both measures partly reflect LDLc levels. Results on gender agree
with studies in older children as well [8,9]. Women with higher
parity (2 or more children before the index pregnancy) had
children with lower nHDLc. Rona et al. showed an inverse
association between parity and TC in 9-year old children [9].
Regarding breastfeeding, we found that longer breastfeeding
duration (.11 months) was associated with lower nHDLc levels
when compared to shorter duration (#1 month). A systematic
review of observational studies concluded that breastfed infants
have higher plasma TC and LDLc levels than their formula-fed
counterparts during the first year of life [12]. This may be
explained by differences in the composition of breast milk and
infant formulas, the former having higher content of cholesterol
and saturated fatty acids, but lower PUFAs [51]. However, results
obtained in preschool children are mixed: three studies found no
association [38,52,53] while two studies reported associations with
TC levels in opposite directions [7,11]. Although it is possible that
the elevation of cholesterol levels associated with breastfeeding is
transient and weakens or vanishes after weaning, more studies are
needed to draw definitive conclusions. Lastly, it is worth noticing
the positive association between maternal smoking and children’s
TC and nHDLc, which is in line with Bekkers et al., who found
that 8-year-old children whose mothers smoked during pregnancy
had about 0.15 units higher TC/HDLc than children from
mothers who did not [6]. The low number of women in our study
who smoked during pregnancy (3%) may have limited the power
to detect a significant association. Still, the consistency between
our results and those by Bekkers et al. suggests a true effect of
maternal smoking on children’s blood cholesterol levels which
warrants confirmation.
A limitation of our study is the lack of infant’s dietary
information. Hence, we could not check the contribution of diet
to plasma cholesterol levels nor investigate the presence of gene-
diet interactions. While interactions between FADS SNPs and diet
were found in two studies in adults and adolescents [25,34], no
significant interaction was found in a study of 10-year-old children
[35].
The studied SNPs explained only a low percentage of variance
in plasma lipid level. This was not surprising, considering that
several common gene variants discovered through GWAS can also
explain, in aggregate, a relatively low percentage of the total
variance (about 10%) [13]. Still, it is remarkable that in our study
one SNP alone is able to explain as much variance in TC as the
non-genetic determinants studied, and to be associated with an 8%
difference between genotype groups.
In conclusion, in this study we have shown that FADS SNPs are
associated with TC and HDLc levels already in infants of 2 years
of age, and that the studied SNPs explain about the same amount
of variance in TC levels as traditional non-genetic determinants.
With this, we provide a new piece of evidence to explain how
blood lipid levels may track from childhood to adulthood and to
gain insight into the mechanisms that define plasma lipid levels in
childhood. We believe that further knowledge on the genetic
determinants of plasma lipids will come from the study of other
common and rare genetic variants, gene-gene, and gene-environ-
ment interactions.
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